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The factors mediating the accumulation of thyroglo-
bulin are of great importance to the understanding of
the pathogenesis of human and experimentally
induced colloid goiters. To elucidate further the
underlying cellular mechanism, thyroid fragments
from newborn rats were incorporated into semisolid
alginate beads and were cultured as three-dimensional
organoids for up to 21 d. In five parallel cultures, the
medium contained either no supplements (group A),
NaI (group B), thyroid-stimulating hormone (TSH)
(group C), NaI plus TSH in the same concentrations as
B and C (group D), or NaI and TSH (as in group D) plus
methimazole (MMI, group E). The thyroid organoids
maintained morphological integrity, functional activ-
ity, and ability to proliferate in vitro. Addition of iodine
to the cultures significantly increased mean (±SEM)
follicular diameters from 19.5 ± 0.7 µm in controls to
33.9 ± 2.2 µm (p < 0.0001) when NaI was added alone
(group B), and 30.4 ± 1.7 µm (p < 0.0001) when com-
bined with TSH (group D). The effect of NaI on folli-
cular size was abolished by MMI (group E, follicular
diameter 23.5 ± 1.3 µm). The results presented sup-
port the recent finding, using a rat colloid goiter model,
that not only TSH but also iodine organification or its
inhibition are important factors in modulating follicu-
lar morphology.
Key Words: Follicular diameter; alginate culture; thy-
roid gland; baby rat.
Introduction
The pathogenesis of colloid goiter has been a subject of
debate for many years. In the 1920s, it was proposed that
colloid-rich goiters developed in hyperplastic glands, after
the removal of the goitrogenic stimulus (1,2). This concept
was generally accepted for 50 yr (3,4). However, it
explained neither the observation that colloid accumu-
lation occurs in most goiters exposed to chronically
increased thyroid-stimulating hormone (TSH) (which is
still a causative factor of many endemic goiters) nor
the coexistence of microfollicular areas containing little
colloid and macrofollicular colloid-rich areas in simple
goiters (5–8).
Later, it became apparent that the supply of thyroid
iodine was also an important factor in the development of
colloid goiters. It was reported that thyroglobulin accumu-
lated in the thyroid glands of rats and mice injected with
TSH and, at the same time, fed a high iodine diet (9). Fur-
thermore, it could be shown that colloid goiters could be
induced in rats and mice by treatment with 5,5-diphenyl-2-
thiohydantoin (DPTH) (10). This substance raises TSH by
increasing fecal loss of thyroid hormones and inhibiting
the conversion of thyroxine (T4) to triiodothyronine (T3),
without influencing iodine uptake/organification by the
thyroid gland (3,11). By contrast, when iodine organi-
fication was blocked by methimazole (MMI) in DPTH-
treated rats, hyperplastic, microfollicular goiters developed
(10). These reports clearly established the idea that colloid
accumulation not depends on intense TSH stimulation but
also on thyroidal iodine uptake.
The extracellular matrix (ECM) and its specialized
form, the basement membrane (BM), play very important
roles in the replication, organization and biological func-
tion of cells (for a review, see ref. 12). Therefore, it would
seem possible that variations in the ECM/BM might be
involved in disease states of tissues, particularly those in
which alterations in tissue structure are involved, e.g., in
goiter or tumor growth. The ECM/BM in the thyroid has
received relatively little attention. Recently, we described
the distribution patterns of various ECM/BM components
(laminin, collagen IV, perlecan, fibronectin, osteonectin
and some laminin variants) in normal and toxic adenomatous
human thyroid tissue (13). Although there were no striking
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differences in the composition of the ECM/BM in the
adenomas studied, there was a quite marked production of
fibronectin in the capsules surrounding the adenomas (13).
In a further report, we were able to show the ability of
the alginate gel culture system to retain ECM and follicular
structure of rat thyroid tissue. In addition, iodine organi-
fication was maintained in the cultured organoids (14).
The present study was undertaken with two aims: first,
to confirm the influence of iodine supply on colloid accu-
mulation previously demonstrated in vivo (9,10) in a
defined in vitro model using thyroid fragments from new-
born rats; and, second, to study the distribution patterns of




Table 1 summarizes the measurements of follicular
diameter from the five groups studied. Follicular diameter
was significantly increased in groups B (NaI) and D (NaI/
TSH). This increase in follicular diameter was apparently
inhibited when iodine uptake by the cells was blocked by
the addition of MMI to the culture medium (group E).
These differences in follicular size are illustrated in Fig. 1,
which shows immunohistochemical staining for thyroglo-
bulin in the five groups. In cultures treated with NaI (group
B) or NaI plus TSH (group D), large follicles are present
filled with thyroglobulin containing colloid. In group E,
which was treated with MMI, the follicles are small and
the colloid is almost absent.
BM components collagen IV, fibronectin, perlecan, and
laminin were investigated by immunohistochemical stain-
ing; Fig. 2 shows an example of the results obtained for
laminin. Staining for this BM component was observed
around individual follicles in all five groups, and there was
no apparent difference in the intensity of the staining
among the groups. Similar results were found for the other
BM components (data not shown).
5-Bromo-2-deoxyuridine (BrdU) incorporation and
immunostaining showed that all groups contained divid-
ing cells (data not shown).
Discussion
Some years ago, in an in vivo model, it was shown that
DPTH induces large colloid-rich goiters by increasing fecal
loss of thyroid hormones and inhibiting conversion of T4 to
T3 (10), thereby increasing endogenous TSH and inducing
goiters without impairing iodine binding. DPTH goiters
treated with MMI were microfollicular, although serum TSH
was increased to the same level as in the goiters treated with
DPTH alone. These findings supported our hypothesis that
the degree of iodine organification and not TSH is the deci-
sive factor in determining thyroid follicular size (9,10).
The results of the present study confirm our earlier in
vivo experiments (9,10). Contrary to the classical concept
(2) that colloid goiters are only produced from originally
hyperplastic microfollicular goiters when the goitrogenic
stimulus ceases, we have shown, in vitro, that elevated TSH
and colloid accumulation are not mutually exclusive
effects. Tissue treated with iodine (group B) has follicular
diameters nearly twice as large as those of the control group
(Table 1). The simultaneous exposure of the tissue to TSH
and iodine (group D) demonstrates that TSH has no addi-
tional effect on the follicular diameters. However, the inhi-
bition of iodine organification by MMI reverses the
iodine-induced increase in follicular diameter (group E).
TSH alone dose not significantly affect the follicular
diameter (group C). The BrdU incorporation experiment
confirms that the cells, in all groups, are dividing in the
alginate beads. It is now clear that iodine organification or
its inhibition is also an important factor influencing
whether thyroid tissue becomes micro- or macrofollicular.
Immunohistochemical studies on the basement mem-
brane components laminin, fibronectin, perlecan, and col-
lagen IV have confirmed their presence and normal
distribution in the alginate-embedded tissue. However,
there was no obvious difference between the groups.
Although iodine can affect follicular size, these results sug-
gest that none of the culture media supplements used in
this study affect the BM composition.
This in vitro model will facilitate further investigations
into the regulation of follicle size and thyroglobulin accu-
mulation, under defined in vitro conditions.
Table 1
Mean Follicular Diameters (±SEM)
Group
A B C D E
Treatment Control NaI TSH NaI/TSH NaI/TSH/MMI
n 124 136 58 146 103
Follicular
diameter (µm) 19.5 ± 0.7 33.9 ± 2.2a 23.6 ± 1.4b 30.4 ± 1.7a 23.5 ± 1.3b,c
ap < 0.0001 vs control.
bp < 0.0001 vs B.
cp < 0.0001 vs D. (All other statistical differences are not significant.)
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Fig. 1. Immunohistochemical staining for thyroglobulin in each of the treated groups: (A) Control group A, no supplements;
(B) group B (1 µM NaI); (C) group C (1 U/L TSH); (D) group D (1µM NaI/1 U/L TSH); and (E) group E (1 µM NaI/1 U/L TSH
and 1 mM MMI). In cultures treated with NaI (B) or NaI plus TSH (D), large follicles filled with thyroglobulin-containing
colloid are present. In group E, which was treated with MMI in addition to NaI and TSH, follicles are small and the colloid is
almost absent.
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Fig. 2. Immunohistochemical staining for laminin in each of the tested groups: (A) Control group A, no supplements; (B)
group B (1 µM NaI); (C) group C (1 U/L TSH); (D) group D (1µM NaI/1 U/L TSH); and (E) group E (1 µM NaI/1 U/L TSH
and 1 mM MMI). The BM component laminin is expressed and shows a normal distribution. However there is no obvious
difference among the groups.
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Materials and Methods
Culture of Thyroid Organoids
Newborn Wistar rats weighing approx 25 g and not older
than 48 h (from the Institute of Pathophysiology, Univer-
sity of Bern, Switzerland) were used. They were killed by
CO2 exposure in a closed chamber and were then thy-
roidectomized under aseptic conditions. Five independent
experiments with a total of 50 animals were performed. All
animal experimentation was conducted with the highest
standards of animal care, according to the ethical principles
and guidelines of the Swiss Academy of Medical Sciences
and approved by governmental authorities.
The thyroid tissue was cultured in a semisolid alginate
bead system composed exclusively of polymerized algi-
nate (Keltone LV, Kelco, Chicago, IL), which allows
three-dimensional growth of follicles, cell clusters, and
organoids, and itself contains no ECM components
(13,15). To initiate the cultures, each thyroid lobe was
sliced into four pieces of about 1 mm side length, and the
tissue was left in Coon’s F-12 medium, supplemented with
penicillin (100 U/mL), streptomycin (100 µg/mL), L-
glutamine (200 nM) (Seromed, Biochrom KG, Berlin,
Germany), 5% newborn calf serum (Seromed), insulin (1.7
µM), transferrin (55.6 nM), hydrocortisone (8.8 nM),
glycin-L-histidyl-L-lysine (29.7 nM), and somatostatin (6.1
nM) (Sigma Division of Fluka, Buchs, Switzerland) with-
out TSH for 24 h. The tissue was then incorporated into
alginate beads approx 5 mm in diameter as previously
described (13,14). The beads were randomly distributed
among five groups (A–E). Group A was the control group
in which no additions were made to the medium. In groups
B–E the culture medium was supplemented as follows: B,
NaI (1 µM); C, TSH (1U/L, Thytropar, Rover, Fort Wash-
ington, PA); D, NaI and TSH of the same concentrations as
groups B and C; E, NaI, TSH, and MMI (1 mM, Fluka AG,
Buchs SG, Switzerland). The thyroid organoids were cul-
tured for up to 21 d, during which the culture medium was
changed every 2 to 3 d. In two of the five experiments, cell
proliferation was documented by the incorporation of
BrdU (Sigma, St. Louis, MO) into newly synthesized DNA
during S-phase of the proliferating thyroid tissue in cul-
ture. BrdU can later be visualized in paraffin sections of
cell clusters and organoids by indirect immunohistochem-
istry (16,17). BrdU was added to the culture medium at a
concentration of 0.06 mg/mL for the last 14 h before har-
vesting the cells.
At the end of the culture period, the beads were fixed in
4% phosphate-buffered formalin, pH 7.4, containing 7 mM
CaCl2. The alginate was then dissolved in a sodium citrate
buffer (150 mM NaCl, 55 mM Na citrate, 20 mM EDTA,
pH 5.1). The cell clusters and organoids released were pro-
cessed into a cell block using a Shandon cytoblock kit
(Shandon, Pittsburgh, PA) and embedded in paraffin for
further analyses, as previously described (13,14).
Morphological and Immunohistochemical Studies
Two-micrometer paraffin sections were stained with
periodic acid Schiff and hematoxylin for morphological
and morphometric analyses. Follicle diameters were mea-
sured with a test screen (linear test circle series) according
to Weibel (18). At least 58 follicles from each group were
evaluated. For the first three experiments, photographs
were taken of each section (magnification ×273), and all
follicles visible in the photographs were measured. For the
last two experiments, a Visopan 314 projection microscope
(Reichert-Jung, Vienna, Austria; magnification ×500) was
used with the same test screen as in the first three experi-
ments. Mean and standard error of the mean (SEM) of fol-
licular diameters were calculated (Table 1).
Alkaline phosphatase immunohistochemical staining of
paraffin sections was used to study the distribution of ECM
components. An indirect immunohistochemical method
was performed as previously described (14) using rabbit
polyclonal primary antibodies to EHS laminin (Sigma),
human fibronectin (Dako A/S, Glostrup, Denmark), mouse
collagen IV (Becton Dickenson), perlecan (kindly provided
by Prof. J. Hassel, University of Pittsburgh, Pittsburgh, PA),
and a swine antirabbit alkaline phosphatase–conjugated
secondary antibody (Dako).
Thyroglobulin was also localized using the same method,
with a rabbit polyclonal human thyroglobulin antibody
(Dako) crossreacting with rat thyroglobulin and the same
secondary antibody as just described.
BrdU was visualized using a triple antibody method
with a mouse monoclonal bromodeoxyuridine antibody
(Dako) followed by rabbit antimouse immunoglobulins
(Dako) and finally mouse monoclonal alkaline phos-
phatase antialkaline phosphatase (Dako). The second and
third steps were repeated, and the sections were then
exposed to the substrate solution for 25 min, as previously
described (14). The slides were then rinsed overnight in
running tap water, counterstained with hematoxylin, and
sealed with Entellan (Merck, Darmstadt, Germany).
Statistical Analyses
Results of the measurements of follicular diameters are
presented as means ± SEM (Table 1). Statistical differences
among the groups were tested by one-way analysis of vari-
ance using the Bonferroni/Dunn post-hoc test.
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